Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500109841Phase 4Not yet recruiting
Phase 4, open-label trial of dexmedetomidine in fever (3 arms), sponsored by Affiliated Women and Children's Hospital of Ningbo University. Primary endpoints: Serum inflammatory factors, Postpartum fever rate and 2 more. Planned start Sep 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500109841.